FGF2 抗体
(Fibroblast Growth Factor 2 (Basic) (FGF2))
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| FGF2 抗体 (AA 143-250) | 小鼠 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 | 人 | 兔 Monoclonal |
|
|
|
| FGF2 抗体 (AA 159-288) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant FGF2 抗体 | 人 | 兔 Monoclonal |
|
|
|
| FGF2 抗体 (AA 189-288) | 人 | 小鼠 Monoclonal |
|
|
|
| FGF2 抗体 (AA 143-288) | 人 | 小鼠 Monoclonal |
|
|
|
| FGF2 抗体 (AA 26-153) (APC) | 兔 | 豚鼠 Polyclonal |
|
|
|
| FGF2 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 (Middle Region) | 人, 小鼠, 大鼠, 兔, Cow, 犬, 豚鼠, 斑马鱼, 马, 绵羊 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 | 人 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| FGF2 抗体 (AA 143-288) | 人 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 (AA 10-155) | 人 | 小鼠 Monoclonal |
|
|
|
| FGF2 抗体 (C-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 (AA 10-154) | 小鼠 | 兔 Polyclonal |
|
|
|
| Recombinant FGF2 抗体 | 人 | Human Monoclonal |
|
|
|
| FGF2 抗体 | Cow | 兔 Polyclonal |
|
|
|
| FGF2 抗体 (C-Term) | 人, 小鼠, 大鼠, 兔, 豚鼠, 斑马鱼, 猴 | 兔 Polyclonal |
|
|
|
| FGF2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| FGF2 抗体 (AA 10-154) | 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
18 references - 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 143-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 159-288
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 24GB4420
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1A9B2
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 189-288
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1D6B5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 143-288
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 兔
- 宿主
- 豚鼠
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 26-153
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow, 犬, 豚鼠, 斑马鱼, 马, 绵羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2H5G2C11
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 143-288
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2H11
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 10-155
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 10-154
Primary Antibody
- SDS (SDS-PAGE: 有验证图片)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: 有验证图片)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- BLI (Bio-Layer Interferometry: 所列应用)
- Func (Functional Studies: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- HuGAL-F2)
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2SA
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 10-154
Latest Publications for our FGF2 抗体
: "Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with ..." in: Journal of cellular physiology, Vol. 234, Issue 10, pp. 18544-18559, (2020) (PubMed).
: "B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model." in: Eye (London, England), Vol. 32, Issue 7, pp. 1220-1231, (2019) (PubMed).
: "Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase." in: Oncotarget, Vol. 7, Issue 26, pp. 39302-39315, (2018) (PubMed).
: "Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro." in: Oncology letters, Vol. 15, Issue 5, pp. 6469-6474, (2018) (PubMed).
: "Electroacupuncture facilitates implantation by enhancing endometrial angiogenesis in a rat model of ovarian hyperstimulation." in: Biology of reproduction, (2018) (PubMed).
: "Role and regulation of growth plate vascularization during coupling with osteogenesis in tibial dyschondroplasia of chickens." in: Scientific reports, Vol. 8, Issue 1, pp. 3680, (2018) (PubMed).
: "Expression of osteoprotegerin and receptor activator for the nuclear factor-κB ligand in XACB/LV-bFGF/MSCs transplantation for repair of rabbit femoral head defect necrosis." in: Journal of cellular biochemistry, (2018) (PubMed).
: "The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model." in: Current eye research, Vol. 41, Issue 3, pp. 367-76, (2016) (PubMed).
: "Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies." in: Oncotarget, Vol. 7, Issue 28, pp. 44735-44762, (2016) (PubMed).
: "Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein ..." in: Oncology letters, Vol. 11, Issue 1, pp. 491-499, (2016) (PubMed).
: "B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model." in: Eye (London, England), Vol. 32, Issue 7, pp. 1220-1231, (2019) (PubMed).
: "Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase." in: Oncotarget, Vol. 7, Issue 26, pp. 39302-39315, (2018) (PubMed).
: "Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro." in: Oncology letters, Vol. 15, Issue 5, pp. 6469-6474, (2018) (PubMed).
: "Electroacupuncture facilitates implantation by enhancing endometrial angiogenesis in a rat model of ovarian hyperstimulation." in: Biology of reproduction, (2018) (PubMed).
: "Role and regulation of growth plate vascularization during coupling with osteogenesis in tibial dyschondroplasia of chickens." in: Scientific reports, Vol. 8, Issue 1, pp. 3680, (2018) (PubMed).
: "Expression of osteoprotegerin and receptor activator for the nuclear factor-κB ligand in XACB/LV-bFGF/MSCs transplantation for repair of rabbit femoral head defect necrosis." in: Journal of cellular biochemistry, (2018) (PubMed).
: "The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model." in: Current eye research, Vol. 41, Issue 3, pp. 367-76, (2016) (PubMed).
: "Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies." in: Oncotarget, Vol. 7, Issue 28, pp. 44735-44762, (2016) (PubMed).
: "Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein ..." in: Oncology letters, Vol. 11, Issue 1, pp. 491-499, (2016) (PubMed).
Aliases for FGF2 抗体
fibroblast growth factor 2 (FGF2) 抗体fibroblast growth factor 2 (Fgf2) 抗体
fibroblast growth factor 2 (basic) (fgf2) 抗体
fibroblast growth factor 2 (fgf2) 抗体
BFGF 抗体
bFGF 抗体
FGF-2 抗体
Fgf-2 抗体
FGFB 抗体
Fgfb 抗体
HBGF-2 抗体
您还需要查找其他产品吗？
You are here:
